Raymond James & Associates Coll Plant Biotechnologies LTD Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding CLGN
# of Institutions
16Shares Held
2.01MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC485KShares$2.04 Million0.21% of portfolio
-
Pinnacle Associates LTD468KShares$1.97 Million0.04% of portfolio
-
Investment Management Of Virginia LLC464KShares$1.95 Million0.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$1.16 Million2.69% of portfolio
-
Brown Advisory Inc119KShares$501,7530.0% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $46.6M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...